eViralHepatitis Review

Medications for CHB

Take our post-test [https://elit.dkbmed.com/issues/154/test] to claim CME credits. To listen to our full-length podcast, click here [https://elit.dkbmed.com/issues/155]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

To Treat or Not To Treat

Take our post-test [https://elit.dkbmed.com/issues/154/test] to claim CME credits. To listen to our full-length podcast, click here [https://elit.dkbmed.com/issues/155]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

HBV & Coinfections

Take our post-test [https://elit.dkbmed.com/issues/154/test] to claim CME credits. To listen to our full-length podcast, click here [https://elit.dkbmed.com/issues/155]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Hepatitis B: Our Current Understanding

Hepatitis B. It may not be curable yet, but as our knowledge continues to grow, so does our ability to benefit our patients today as we prepare them for tomorrow. That’s the focus of this Special HBV Edition of eViralHepatitis Review. The first part of this program presented an evidence-based expert commentary by eViralHepatitis Review Program Director Dr. Mark Sulkowski — Professor of Medicine at Johns Hopkins and Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. This second part is an interview providing more in-depth discussions between Dr. Sulkowski and three of medicine’s top CHB experts.  Take our post-test [https://elit.dkbmed.com/issues/155/test] to claim CME credits. To read a companion newsletter click here [https://elit.dkbmed.com/issues/154]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

HBV: Next Steps to a Cure

Take our post-test [https://elit.dkbmed.com/issues/68/test] to claim CME credits. To read a companion newsletter click here [https://elit.dkbmed.com/issues/67]. Why has finding a cure for hepatitis B infection been so challenging? What is it about this virus and its life cycle that makes it so different from curable HCV? In this issue, Dr. Marion Peters from the University of California San Francisco and Northwestern University explains the obstacles researchers face in their quest to tame this virus.  ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.